ArticleLipids in health and disease2025
Bidirectional genetic overlap between psychiatric disorders and high-density lipoprotein cholesterol levels.
Article in Lipids in health and disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Individuals with psychiatric disorders can show differences in plasma high-density lipoprotein cholesterol (HDL-C), although whether they share a common genomic basis is unclear. This study relied on publicly summarized data from genome-wide association studies for HDL-C and major psychiatric disorders to evaluate shared genetic architecture. Correlation between traits was summarized via linkage disequilibrium score regression. Using a bivariate causal mixture model, polygenicity was quantified alongside sharing versus trait-specificity. Jointly associated loci were mapped with a conjunctional false discovery rate approach. Analyses indicated polygenic overlap between HDL-C and several psychiatric disorders; the pattern differed across disorders. Mapped signals were primarily noncoding in available annotations, consistent with regulatory mechanisms. These findings did not establish causality or immediate clinical utility. They were compatible with attention to metabolic health in psychiatric care when clinically indicated and motivated prospective validation across diverse populations to support equitable applicability and clarify clinical significance.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.